Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 3
Submit an article Journal homepage
860
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA MRPS30 divergent transcript can be detected in the cytoplasm of triple-negative breast cancer cells and is targeted by microRNA-130b

Dongtao Wanga Department of Oncological Surgery, Central Hospital, Baotou, Inner Mongolia, P.R. ChinaView further author information
,
Qiang Songb Department of General Surgery, Central Hospital, Baotou, Inner Mongolia, P.R. ChinaView further author information
,
Tianyong Zhaoa Department of Oncological Surgery, Central Hospital, Baotou, Inner Mongolia, P.R. ChinaView further author information
,
Fang Wanga Department of Oncological Surgery, Central Hospital, Baotou, Inner Mongolia, P.R. ChinaView further author information
,
Yang Yua Department of Oncological Surgery, Central Hospital, Baotou, Inner Mongolia, P.R. ChinaView further author information
,
Jing Qia Department of Oncological Surgery, Central Hospital, Baotou, Inner Mongolia, P.R. ChinaView further author information
,
Pengfei Lyuc Department of Breast Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou City, Hainan Province, PR. ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-2192-0768View further author information
ORCID Icon &
Xiangyang Duand Central Blood Station, Baotou, Inner Mongolia, P.R. ChinaView further author information
 show all
Pages 5954-5961 | Received 27 Oct 2021, Accepted 11 Jan 2022, Published online: 22 Feb 2022

References

  • Waks AG, Winer EP. Breast cancer treatment: a review. Jama. 2019;321(3):288–300.
  • Ginsburg O, Yip CH, Brooks A, et al. Breast cancer early detection: a phased approach to implementation. Cancer. 2020;126(Suppl 10):2379–2393.
  • Denieffe S, Cowman S, Gooney M. Symptoms, clusters and quality of life prior to surgery for breast cancer. J Clin Nurs. 2014;23(17–18):2491–2502.
  • Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer. 2010;17(4):R245–62.
  • Dawood S, Hu R, Homes MD, et al. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat. 2011;126(1):185–192.
  • Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9(2):176–198.
  • Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med. 2015;12(2):106–116.
  • Kim K, Park HJ, Shin KH, et al. Breast conservation therapy versus mastectomy in patients with T1-2N1 triple-negative breast cancer: pooled analysis of KROG 14-18 and 14-23. Cancer Res Treat. 2018;50(4):1316–1323.
  • Chen QX, Wang XX, Lin PY, et al. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database. Oncotarget. 2017;8(3):4773–4780.
  • Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016;293(2):247–269.
  • Campone M, Valo I, Jézéquel P, et al. Prediction of recurrence and survival for Triple-Negative Breast Cancer (TNBC) by a protein signature in tissue samples. Mol Cell Proteomics. 2015;14(11):2936–2946.
  • Neophytou C, Boutsikos P, Papageorgis P. Molecular mechanisms and emerging therapeutic targets of triple-negative breast cancer metastasis. Front Oncol. 2018;8:31.
  • Jiang MC, Ni JJ, Cui WY, et al. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9(7):1354–1366.
  • Liu Y, Sharma S, Watabe K. Roles of lncRNA in breast cancer. Front Biosci (Schol Ed). 2015;7:94–108.
  • Yang W, Qian Y, Gao K, et al. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes. Carcinogenesis. 2021;42(1):80–92.
  • Kim Y, Kim H, Bang S, et al. MicroRNA-130b functions as an oncogene and is a predictive marker of poor prognosis in lung adenocarcinoma. Lab Invest. 2021;101(2):155–164.
  • Zhang J, Liu D, Deng G, et al. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p. Bioengineered. 2021;12(2):12070–12086.
  • Sun X, Luo Z, Gong L, et al. Identification of significant genes and therapeutic agents for breast cancer by integrated genomics. Bioengineered. 2021;12(1):2140–2154.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402–408.
  • Yu T, Cao R, Li S, et al. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. BMC Cancer. 2015;15(1):29.
  • Chen Q, Zhao X, Zhang H, et al. MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. Mol Carcinog. 2015;54(11):1292–1300.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.